Learn what the monitoring requirements, and targets associated with HbA1c and cholesterol results, are for people with type 2 diabetes, interpret those results accurately, and develop strategies to support patients in achieving their targets.
1h:00m (for events this includes pre and post event learning)
The aim of this e-learning programme is to provide learners with a basic awareness of important blood tests and how to interpret them in order to support the diagnosis and management of patients. Section 2 covers chronic disease markers, urea and electrolytes and liver function tests.
There are three sections which make up this learning programme. To access the other sections, select the links below:
Please note: this e-learning programme has been developed and provided by the Welsh Centre for Pharmacy Professional Education (WCPPE). Users should recognise that this programme may refer to Welsh policies and organisations. CPPE does not maintain control over the accuracy and currency of this programme.
3h:00m (for events this includes pre and post event learning)
Learning Objectives:On completion of all three sections of this learning programme you should be able to:
The aim of this e-learning programme is to provide you with a better understanding of vascular risk and the NHS health check programme.
It looks at the health policy surrounding the NHS health check programme and how it is commissioned. This learning defines cardiovascular risk and looks at some of the different assessment tools available and how these are used to estimate an individual’s cardiovascular risk.
It looks at the importance of communication with patients about their modifiable risk factors. Information on how to perform the NHS health check has been included and how to embed clinical governance into your NHS health check service.
6h:00m (for events this includes pre and post event learning)
Learning Objectives:On completion of this learning programme you should be able to:
This e-learning programme outlines the risk factors of stroke, pharmacological management of acute stroke, and secondary prevention. It equips learners to provide a comprehensive service to stroke patients, and to patients who may be at risk of stroke. This e-learning explores hyperlipidaemia as a risk factor for ischaemic stroke.
NICE CG181 Cardiovascular disease: risk assessment and reduction, including lipid modification
This guideline covers identifying and managing familial hypercholesterolaemia (FH – a specific type of high cholesterol that runs in the family) in children, young people and adults.
Please help us improve our website by letting us know what you like and reporting anything that isn't quite right.